EntrarCadastrar

/

Fosaprepitant

Visão geral

Fosaprepitant is an antiemetic medication, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved for medical use in the United States, and in the European Union in January 2008

A Anant Labs fabrica e fornece impurezas de Fosaprepitant de alta qualidade para o mercado global. Nossas impurezas EP de Fosaprepitant são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Ingrediente Farmacêutico Ativo

Chemical structure of Fosaprepitant

Fosaprepitant

Mol. Formula: C₂₃H₂₂F₇N₄O₆P
Mol. Weight: 614.411

Impurezas (5)

Chemical structure of Aprepitant Impurity 1 Enantiomer HCl

Aprepitant Impurity 1 Enantiomer HCl

Cat. No.: ANT-FSP-004
CAS: 171482-05-6
Mol. Formula: C₂₀H₁₉ClF₇NO₂
Mol. Weight: 473.82

Chemical structure of Aprepitant Process Impurity 3

Aprepitant Process Impurity 3

Cat. No.: ANT-FSP-005
CAS: 155742-64-6
Mol. Formula: C₄H₈ClN₃O₂
Mol. Weight: 165.58

Chemical structure of Dibenzyl Phosphate Impurity

Dibenzyl Phosphate Impurity

Cat. No.: ANT-FSP-003
CAS: 1623-08-1
Mol. Formula: C₁₄H₁₅O₄P
Mol. Weight: 278.24

Chemical structure of Fosaprepitant Dimeglumine

Fosaprepitant Dimeglumine

Cat. No.: ANT-FSP-02
CAS: 265121-04-8
Mol. Formula: C₃₇H₅₆F₇N₆O₁₆P
Mol. Weight: 1004.84

Chemical structure of Fosaprepitant Dimeglumine Aprepitant Impurity

Fosaprepitant Dimeglumine Aprepitant Impurity

Cat. No.: ANT-FSP-01
CAS: 170729-80-3
Mol. Formula: C₂₃H₂₁F₇N₄O₃
Mol. Weight: 534.43